Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | POLA1 | P09884 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 3/20 | 0.35 |
| ▸ | CES1 | P23141 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28884010 | 0.94 | TSHR (0.50) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL35755 | 0.91 | CYP4F2 (0.46) | TSHRCYP4F2CYP4A11MAPTCES2 | |
| SCHEMBL19469710 | 0.91 | CYP4F2 (0.46) | TSHRCYP4F2CYP4A11MAPTCES2 | |
| SCHEMBL7051547 | 0.91 | CYP4F2 (0.46) | TSHRCYP4F2CYP4A11MAPTCES2 | |
| SCHEMBL4892247 | 0.90 | TSHR (0.55) | TSHRDGKACYP4F2CYP4A11LMNA | |
| SCHEMBL15416699 | 0.89 | CYP4F2 (0.43) | TSHRCYP4F2CYP4A11MAPTPOLB | |
| SCHEMBL28690648 | 0.89 | TSHR (0.60) | TSHRDGKACYP4F2CYP4A11LMNA | |
| SCHEMBL380332 | 0.88 | TSHR (0.50) | TSHRDGKALMNAPAMALDH1A1 | |
| SCHEMBL248383 | 0.86 | TSHR (0.54) | TSHRDGKALMNAPAMMAPT | |
| SCHEMBL245031 | 0.86 | TSHR (0.54) | TSHRDGKALMNAPAMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008771-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2024-01-11 | — | — | WO | claimed |
| CN-110730653-B | Cosmetic composition comprising pullulan derivatives | LVMH研究公司 | 2023-08-22 | — | — | CN | claimed |
| US-11253462-B2 | Cosmetic composition comprising a pullulan derivative | LVMH RECHERCHE (FR) | 2022-02-22 | — | — | US | claimed |
| US-20200138692-A1 | COSMETIC COMPOSITION COMPRISING A PULLULAN DERIVATIVE | LVMH RECHERCHE (FR) | 2020-05-07 | — | — | US | claimed |
| CN-110730653-A | Cosmetic composition comprising pullulan derivative | LVMH研究公司 | 2020-01-24 | — | — | CN | claimed |
| US-4367220-A | COMPOSED OF LIPOSOLUBLE VINYL ESTER POLYMER UNITS, 1-DOCOSANOYLOXY-3-(2-ETHYL)-HEXYLOXY-2-PROPANOL, FAT AND COLORING MATERIAL | L'OREAL (FR) | 1983-01-04 | — | — | US | claimed |
| US-12004630-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-06-11 | — | — | US | disclosed |
| US-11998104-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-06-04 | — | — | US | disclosed |
| US-11980277-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-05-14 | — | — | US | disclosed |
| US-11974651-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2024-05-07 | — | — | US | disclosed |
| US-20240082142-A1 | EYELASH COATING COMPOSITIONS FOR FALSE EYELASHES | L'OREAL (FR) | 2024-03-14 | — | — | US | disclosed |
| US-20240065963-A1 | MULTICOMPONENT COMPOSITION (Michael Addition) | WELLA INT OPERATIONS SWITZERLAND SARL (CH) | 2024-02-29 | — | — | US | disclosed |
| US-11904042-B2 | Hair coloring composition and methods for its application and removal | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2024-02-20 | — | — | US | disclosed |
| US-20020051759-A1 | Film -forming cosmetic composition | EVONIK OPERATIONS GMBH (DE) | 2002-05-02 | — | — | US | disclosed |
| US-20020044917-A1 | Film-forming cosmetic composition | DE LA POTERIE VALERIE (FR) | 2002-04-18 | — | — | US | disclosed |
| US-20020041857-A1 | Film-forming cosmetic composition | EVONIK DEGUSSA GMBH (DE) | 2002-04-11 | — | — | US | disclosed |
| US-20010006665-A1 | Composition comprising at least one wax and at least one oil | L'OREAL S.A. (FR) | 2001-07-05 | — | — | US | disclosed |
| US-4367220-A | COMPOSED OF LIPOSOLUBLE VINYL ESTER POLYMER UNITS, 1-DOCOSANOYLOXY-3-(2-ETHYL)-HEXYLOXY-2-PROPANOL, FAT AND COLORING MATERIAL | L'OREAL (FR) | 1983-01-04 | — | — | US | disclosed |
| US-RE29871-E | Fatty compositions for use in cosmetic makeup compositions and said cosmetic makeup compositions | L'OREAL (FR) | 1978-12-26 | — | — | US | disclosed |
| US-3937811-A | COPOLYMER | SOCIETE ANONYME DITE: L'OREAL (FR) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020051759-A1 | Film -forming cosmetic composition | KRT18, CUTA, DSG1 | TSHR 2076/4885DGKA 1047/4885CYP4F2 3708/4885 |
| US-11904042-B2 | Hair coloring composition and methods for its application and removal | KRT18, TYR, CD99 | TSHR 1636/4885DGKA 3116/4885CYP4F2 1343/4885 |
| US-11980277-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | TSHR 1719/4885DGKA 1035/4885CYP4F2 4382/4885 |
| US-20010006665-A1 | Composition comprising at least one wax and at least one oil | CUTA, COL14A1, LIPA | TSHR 4641/4885DGKA 260/4885CYP4F2 2315/4885 |
| US-11974651-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | TSHR 1719/4885DGKA 1035/4885CYP4F2 4382/4885 |
| US-20020044917-A1 | Film-forming cosmetic composition | RTF1, RCOR3, AQP3 | TSHR 2048/4885DGKA 2275/4885CYP4F2 1438/4885 |
| US-20020041857-A1 | Film-forming cosmetic composition | KRT18, CUTA, KAT8 | TSHR 1559/4885DGKA 1238/4885CYP4F2 2313/4885 |
| US-11998104-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | TSHR 1719/4885DGKA 1035/4885CYP4F2 4382/4885 |
| US-20240065963-A1 | MULTICOMPONENT COMPOSITION (Michael Addition) | KRT18, EXOSC10, CUTA | TSHR 2840/4885DGKA 4291/4885CYP4F2 4372/4885 |
| US-12004630-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | TSHR 1719/4885DGKA 1035/4885CYP4F2 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.